Buprenorphine transdermal patches (FOI)

​Request

With respect to the following questions, please provide answers for any decisions made since 1 January 2016.

A

Has the Department or its committees recommended prescribing a particular brand or brands of seven day buprenorphine transdermal patches? If so, what brand or brands were recommended to be prescribed?

B

If the Department or its committees recommends prescribing more than one brand of 7 day buprenorphine transdermal patches what, if any, guidance is there on which brand(s) should be prescribed?

C

For each brand of seven day buprenorphine transdermal patches recommended, on what date was the decision made to recommend that brand?

Response

A

No recommendations have been given.

B and C

Not applicable as no recommendations were given.